IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Pharmaco Vigilance and Adverse Drug Reaction Reporting

Perspective, Volume 03 Issue 1 – January to March 2010

Authors

Dr. A Marthanda Pillai, Sr. Consultant Neuro Surgeon, Ananthapuri Hospitals, Kairali, National Highway, Trivandrum 695 024.


Abstract

Pharmaco vigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug – related problem. Various types of Adverse Drug Reactions are described, its mechanisms explained and the importance of recognizing it is mentioned. Training programmes to help detect ADRs are needed. The method of providing a proper ADR report is provided.
Monitoring of adverse drug reactions is an ongoing, ceaseless and continuing process. Given the limitation of clinical trials in identifying rare and delayed ADR‘s, and the need for comprehensive safety profiles, the importance of reporting ADR‘s cannot be over-emphasized. Given the limitation of clinical trials in identifying rare and delayed ADR’s, and the need for comprehensive safety profiles, the importance of reporting ADR‘s cannot be over-emphasized. Most of the time the ADRs mentioned in formularies is based on Western experience. ADR‘s in Indian population can differ, and it is important that we know ADR’s in Indian population and this can be known only if the ADR‘s are reported.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician